2
Most read
3
Most read
TORCH
Foreword
Infections acquired in utero or during the birth process are a significant cause of fetal
and neonatal mortality and an important contributor to early and later childhood
morbidity. The original concept of the TORCH perinatal infections was to group 5
infections with similar presentations, including rash and ocular findings.
Introduction
The TORCH test, which is sometimes called the TORCH panel is actually a category of
blood tests called Infectious-Disease Antibody Titer tests [IDAT]. TORCH tests measure
the presence of antibodies against a specific group of infectious diseases and their level
of concentration in the blood. TORCH is an acronym for a group of 5 infectious
diseases:
• Toxoplasmosis
• Other (Syphilis)
• Rubella (German measles)
• Cytomegalovirus (CMV)
• Herpes Simplex Virus (HSV)
These 5 diseases are relevant as
1. Each disease may be teratogenic;
2. Each crosses the placenta;
3. Each may adversely affect the developing foetus;
4. The effect of each varies, depending on developmental stage at time of
exposure.
All are grouped together because they can cause a cluster of symptomatic birth defects
in newborns, collectively called the TORCH syndrome. The guiding reasons to think of
TORCH infections could be:
• IUGR infants
• Hepatosplenomegaly
• Thrombocytopenia
• Unusual rash
• Bad maternal obstetric history [BOH]
• Classic findings of any specific infection
Bad obstetric history (BOH) implies previous unfavourable foetal outcome in terms of 2
or more consecutive spontaneous abortion, history of intrauterine foetal death,
intrauterine growth retardation, still births, early neonatal death and / or congenital
anomalies. Cause of BOH may be genetic, hormonal, abnormal maternal immune
response and maternal infection. Recurrent pregnancy wastage due to maternal
infections transmissible in utero at various stage of gestation can be caused by a wide
array of organisms which include the TORCH complex.
Background of TORCH diseases
Toxoplasmosis
Caused by Toxoplasma gondii, and is found in human worldwide, a
parasite that the mother can acquire from handling infected cats,
drinking unpasteurized milk, or eating contaminated meat. The
1
infection is carried to the infant through the mother's placenta, and
can cause infections of the eyes or central nervous system. The later
in pregnancy that the mother is infected, the higher the probability
that the fetus will be infected. On the other hand, toxoplasmosis early
in pregnancy is more likely to cause a miscarriage or serious birth
defects.
Syphilis
This disease is added to the TORCH panel because of a rapid
increase in reported cases since 1990. It is also a potentially lifethreatening infection for the fetus.
Rubella
This is a virus that has a seasonal pattern, with epidemics most likely
in the spring. Between 0.1-2% of newborns will be infected with
rubella. The rate of fetal infection varies according to the timing of the
mother's infection during pregnancy. Birth defects, however, are most
likely (85%) in infants infected during the first eight weeks of
pregnancy.
Cytomegalovirus This is also a virus belonging to the herpesvirus group. It can be
(CMV)
transmitted through body secretions, as well as by sexual contact;
some newborns which acquire CMV through the mother's breast
milk. Infected infants may have severe problems, such as hearing
loss, mental retardation, pneumonia, hepatitis, or
blood disorders.
Herpes simplex This is also a virus that enters the infant through his eyes, skin,
mouth, and upper respiratory tract. About 20% of infants born with
HSV infection will have localized infections of the eyes, mouth, or
skin and about 50% of infected infants will develop disease spread
throughout the body (disseminated) within (9-11) days after birth.
HSV-2 is sexually transmitted. Symptoms include genital ulcers or
sores. In addition to oral and genital sores, the virus can also lead to
complications such as infection of the lining of the brain and the brain
itself (meningoencephalitis) or infection of the eye especially the
conjunctiva and cornea.
Mode of transmission
Toxoplasmosis
•
•
•
• Rubella
•
• Cytomegalo
•
virus
•
• Herpes virus
Syphilis
•
•

Handling of excrement of infected cats,
Drinking unpasteurized goat’s milk,
Eating contaminated meat.
Salivary secretions
Secretions from cutaneous ulcers.
Cervical secretions
Sexual contact;
Blood & its products

Time to perform
1. As a routine at the time of 1st antenatal visit;
2
2. Repeat Ig G (Serum) at mid trimester. (possibility of seroconversion);
3. In a suspected pregnancy case, where patients shows Flu-like symptoms & rash
while pregnant;
4. Amniotic fluid testing later.
5. Cord blood to know fetal infection.
Result interpretation
1. Serial serological testing (ELISA) is preferable and diagnosis of acute infection is
made at <12 weeks of gestation if it is +ve for IgG & IgM antibodies.
2. If IgM is -ve & IgG is +ve, repeat after 3 weeks and check for 4-fold rise.
3. If -ve in early pregnancy, perform test at 18-20 weeks of gestation.
(Joul. Of OBGI Feb-2006).
Summary
TORCH screening is now accepted by clinicians as a reliable test for investigating
pregnant women and infants for congenital, perinatal and neonatal TORCH infections.
The IgG antibody in the pregnant woman may be a sign of past infection with one of
these infectious agents. By testing a second blood sample drawn 2 weeks later, the
level of antibody can be compared. If the second blood draw shows an increase in IgG
antibody, it may indicate a recent infection with the infectious agent.
IgM is never zero as it cross-reacts with many other IgMs and other proteins. IgM is a
specific class of antibodies that seeks out virus particles. It is, therefore, the most useful
indicator of the presence of a TORCH infection. Any general abnormal or positive
presence gives high levels of IgM finding. IgM antibodies against TORCH organisms
usually persist for about 3 months, while IgG antibodies remain detectable for a lifetime,
providing immunity and preventing or reducing the severity of reinfection. Thus,
1. If IgM antibodies are present in a pregnant woman, a current or recent infection with
the organism has occurred.
2. If IgM antibodies are absent and IgG antibodies are present and do not demonstrate
an increase on serial testing several weeks later, it can be assumed that the person
has had a previous infection by the corresponding organism, or has been vaccinated
to prevent an infection.
3. If the serum of a person has no evidence of either IgM or IgG antibodies specific for
the organism, then the person is at risk of infection because they do not have any
demonstrable immunity.
Reference:
1. Indian Journal of Medical Microbiology, (2002) 20 (1): 57-58, Prevalence of torch infections in Indian
pregnant women, S Singh
2. Indian Journal of Medical Microbiology, (2003) 21 (2):108-110, seroprevalence of torch infection in
bad obstetric history, D Turbadkar, M Mathur, M Rele.

3

More Related Content

PPTX
Hemolytic disease of newborn Lecture Final Year MBBS
PPTX
Neonatal hypocalcemia
PPTX
Congenital infection
PPTX
Hydrops fetalis
PPTX
Pediatrics OSCE pictures
PPTX
Blood group incompatibility of newborn
PPT
Torch infections
PPTX
Hemolytic disease of newborn Lecture Final Year MBBS
Neonatal hypocalcemia
Congenital infection
Hydrops fetalis
Pediatrics OSCE pictures
Blood group incompatibility of newborn
Torch infections

What's hot (20)

PPTX
Hemolytic disease
PPTX
Hydrops
PPTX
Rh isoimmunization
PPTX
Abo incompatibility
PPTX
Torch infections by Dr. Dilip
PPTX
Seminar prenatal genetic screening
PPTX
Neonatal Jaundice
PPT
Torch Infection
PPTX
Pleural effusion in children
PDF
Neonatal infections
PPTX
Precocious puberty
PPTX
Meconium aspiration syndrome
PPTX
TUBERCULOSIS IN PREGNANCY
PPTX
Rh incompatibility
PPTX
FLUID MANAGEMENT IN NEONATES NICU
PPTX
Hematologic changes of pregnancy
PPTX
Neonatal sepsis
PPTX
Hemolytic disease of the newborn
PPTX
TORCH INFECTION
PPTX
9. birthmarks and naevi
Hemolytic disease
Hydrops
Rh isoimmunization
Abo incompatibility
Torch infections by Dr. Dilip
Seminar prenatal genetic screening
Neonatal Jaundice
Torch Infection
Pleural effusion in children
Neonatal infections
Precocious puberty
Meconium aspiration syndrome
TUBERCULOSIS IN PREGNANCY
Rh incompatibility
FLUID MANAGEMENT IN NEONATES NICU
Hematologic changes of pregnancy
Neonatal sepsis
Hemolytic disease of the newborn
TORCH INFECTION
9. birthmarks and naevi
Ad

Viewers also liked (20)

PPT
Infections in pregnancy 1 3 15
PDF
Infectious diseases in pregnancy
PPTX
PPT
Torch infections
PPT
Torch in pregnany
PPTX
Meningitis
PPSX
Lab diagnosis of ToRCH complex
PPTX
PPT
Diagnosis And Therapy Of Perinatal Infection
PPTX
TERATOGENS
PPTX
Enfermedad de mano pie boca
PDF
Enterovirus
PPT
Management of Abnormal TORCH Results :an update Through case studies
PPTX
Mechanism of cough
PPTX
Torch infection in pregnancy
PPTX
TORCH INFECTIONS
PDF
Torch infections in pregnancy presentation
PPT
Infections in pregnancy
PPT
Recurrent Loss 2009
Infections in pregnancy 1 3 15
Infectious diseases in pregnancy
Torch infections
Torch in pregnany
Meningitis
Lab diagnosis of ToRCH complex
Diagnosis And Therapy Of Perinatal Infection
TERATOGENS
Enfermedad de mano pie boca
Enterovirus
Management of Abnormal TORCH Results :an update Through case studies
Mechanism of cough
Torch infection in pregnancy
TORCH INFECTIONS
Torch infections in pregnancy presentation
Infections in pregnancy
Recurrent Loss 2009
Ad

Similar to Torch (20)

PPTX
TORCH INFECTIONS.pptx TOXOPLASMOSIS CYTOMEGALOVIRUS
PDF
Genetic study of torch infections in women with bad obstetric history multipl...
PPT
34061_TORCH_maranich.ppt
PPTX
Perinatal infections (2)
PPTX
PPTX
TORCH Infections.pptx
PPTX
INTRAUTERINE INFECTIONS (TORCH INFECTIONS)
PPTX
perinatal infection.pptx
PPTX
neonatal infectious diseases categories.pptx
PDF
TORCH (TORCH).pdf
PPTX
TORCH diseases in neonates and its features and testing
PPTX
Torch s in pregnancy
PPTX
416575945-Torch-Infection.pptx. easy model
PPTX
perinatal infections 2-171220190027.pptx
PPTX
Fbgd6hkDe42Xjgl5990.pptx
PPTX
TORCH INFECTIONS IN PREGNANCY.pptx
PPT
Transplacental Cytomegalo virus infections.ppt
PPT
Etiology and lab diagnosis of Congenital Infections.ppt
PDF
Document: TORCH Infections for Step 1 USMLE
PPT
-Torch-Infection-Easier model for starters.ppt
TORCH INFECTIONS.pptx TOXOPLASMOSIS CYTOMEGALOVIRUS
Genetic study of torch infections in women with bad obstetric history multipl...
34061_TORCH_maranich.ppt
Perinatal infections (2)
TORCH Infections.pptx
INTRAUTERINE INFECTIONS (TORCH INFECTIONS)
perinatal infection.pptx
neonatal infectious diseases categories.pptx
TORCH (TORCH).pdf
TORCH diseases in neonates and its features and testing
Torch s in pregnancy
416575945-Torch-Infection.pptx. easy model
perinatal infections 2-171220190027.pptx
Fbgd6hkDe42Xjgl5990.pptx
TORCH INFECTIONS IN PREGNANCY.pptx
Transplacental Cytomegalo virus infections.ppt
Etiology and lab diagnosis of Congenital Infections.ppt
Document: TORCH Infections for Step 1 USMLE
-Torch-Infection-Easier model for starters.ppt

More from BALASUBRAMANIAM IYER (20)

PPTX
Project Status Report PowerPoint Template.pptx
PPT
dyslipidemia6.ppt
PPT
Cancer and immunology
PPT
Stem cells in cardiac care
PPT
Telmisartan combination uses
PPT
PPT
Temisartan + chlorthalidone
PPT
PPT
NGAL - Acute kidney injury biomarker
PPT
Are all arbs the same?
DOC
DOC
Triple maternal screen
PPT
Risk stratification in post cardiac event cases
PPT
Presentation on heart valve devices
Project Status Report PowerPoint Template.pptx
dyslipidemia6.ppt
Cancer and immunology
Stem cells in cardiac care
Telmisartan combination uses
Temisartan + chlorthalidone
NGAL - Acute kidney injury biomarker
Are all arbs the same?
Triple maternal screen
Risk stratification in post cardiac event cases
Presentation on heart valve devices

Recently uploaded (20)

PPTX
The Human Reproductive System Presentation
PPT
Rheumatology Member of Royal College of Physicians.ppt
PPT
Dermatology for member of royalcollege.ppt
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PDF
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PPTX
4. Abdominal Trauma 2020.jiuiwhewh2udwepptx
PPTX
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PPTX
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
PPTX
Hypertensive disorders in pregnancy.pptx
PPTX
SHOCK- lectures on types of shock ,and complications w
PPTX
Wheat allergies and Disease in gastroenterology
PPTX
Reading between the Rings: Imaging in Brain Infections
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
PPTX
Assessment of fetal wellbeing for nurses.
PPTX
Impression Materials in dental materials.pptx
The Human Reproductive System Presentation
Rheumatology Member of Royal College of Physicians.ppt
Dermatology for member of royalcollege.ppt
AGE(Acute Gastroenteritis)pdf. Specific.
OSCE Series Set 1 ( Questions & Answers ).pdf
OSCE SERIES ( Questions & Answers ) - Set 5.pdf
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
4. Abdominal Trauma 2020.jiuiwhewh2udwepptx
ANESTHETIC CONSIDERATION IN ALCOHOLIC ASSOCIATED LIVER DISEASE.pptx
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
NUCLEAR-MEDICINE-Copy.pptxbabaabahahahaahha
Hypertensive disorders in pregnancy.pptx
SHOCK- lectures on types of shock ,and complications w
Wheat allergies and Disease in gastroenterology
Reading between the Rings: Imaging in Brain Infections
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
NRP and care of Newborn.pptx- APPT presentation about neonatal resuscitation ...
Assessment of fetal wellbeing for nurses.
Impression Materials in dental materials.pptx

Torch

  • 1. TORCH Foreword Infections acquired in utero or during the birth process are a significant cause of fetal and neonatal mortality and an important contributor to early and later childhood morbidity. The original concept of the TORCH perinatal infections was to group 5 infections with similar presentations, including rash and ocular findings. Introduction The TORCH test, which is sometimes called the TORCH panel is actually a category of blood tests called Infectious-Disease Antibody Titer tests [IDAT]. TORCH tests measure the presence of antibodies against a specific group of infectious diseases and their level of concentration in the blood. TORCH is an acronym for a group of 5 infectious diseases: • Toxoplasmosis • Other (Syphilis) • Rubella (German measles) • Cytomegalovirus (CMV) • Herpes Simplex Virus (HSV) These 5 diseases are relevant as 1. Each disease may be teratogenic; 2. Each crosses the placenta; 3. Each may adversely affect the developing foetus; 4. The effect of each varies, depending on developmental stage at time of exposure. All are grouped together because they can cause a cluster of symptomatic birth defects in newborns, collectively called the TORCH syndrome. The guiding reasons to think of TORCH infections could be: • IUGR infants • Hepatosplenomegaly • Thrombocytopenia • Unusual rash • Bad maternal obstetric history [BOH] • Classic findings of any specific infection Bad obstetric history (BOH) implies previous unfavourable foetal outcome in terms of 2 or more consecutive spontaneous abortion, history of intrauterine foetal death, intrauterine growth retardation, still births, early neonatal death and / or congenital anomalies. Cause of BOH may be genetic, hormonal, abnormal maternal immune response and maternal infection. Recurrent pregnancy wastage due to maternal infections transmissible in utero at various stage of gestation can be caused by a wide array of organisms which include the TORCH complex. Background of TORCH diseases Toxoplasmosis Caused by Toxoplasma gondii, and is found in human worldwide, a parasite that the mother can acquire from handling infected cats, drinking unpasteurized milk, or eating contaminated meat. The 1
  • 2. infection is carried to the infant through the mother's placenta, and can cause infections of the eyes or central nervous system. The later in pregnancy that the mother is infected, the higher the probability that the fetus will be infected. On the other hand, toxoplasmosis early in pregnancy is more likely to cause a miscarriage or serious birth defects. Syphilis This disease is added to the TORCH panel because of a rapid increase in reported cases since 1990. It is also a potentially lifethreatening infection for the fetus. Rubella This is a virus that has a seasonal pattern, with epidemics most likely in the spring. Between 0.1-2% of newborns will be infected with rubella. The rate of fetal infection varies according to the timing of the mother's infection during pregnancy. Birth defects, however, are most likely (85%) in infants infected during the first eight weeks of pregnancy. Cytomegalovirus This is also a virus belonging to the herpesvirus group. It can be (CMV) transmitted through body secretions, as well as by sexual contact; some newborns which acquire CMV through the mother's breast milk. Infected infants may have severe problems, such as hearing loss, mental retardation, pneumonia, hepatitis, or blood disorders. Herpes simplex This is also a virus that enters the infant through his eyes, skin, mouth, and upper respiratory tract. About 20% of infants born with HSV infection will have localized infections of the eyes, mouth, or skin and about 50% of infected infants will develop disease spread throughout the body (disseminated) within (9-11) days after birth. HSV-2 is sexually transmitted. Symptoms include genital ulcers or sores. In addition to oral and genital sores, the virus can also lead to complications such as infection of the lining of the brain and the brain itself (meningoencephalitis) or infection of the eye especially the conjunctiva and cornea. Mode of transmission Toxoplasmosis • • • • Rubella • • Cytomegalo • virus • • Herpes virus Syphilis • • Handling of excrement of infected cats, Drinking unpasteurized goat’s milk, Eating contaminated meat. Salivary secretions Secretions from cutaneous ulcers. Cervical secretions Sexual contact; Blood & its products Time to perform 1. As a routine at the time of 1st antenatal visit; 2
  • 3. 2. Repeat Ig G (Serum) at mid trimester. (possibility of seroconversion); 3. In a suspected pregnancy case, where patients shows Flu-like symptoms & rash while pregnant; 4. Amniotic fluid testing later. 5. Cord blood to know fetal infection. Result interpretation 1. Serial serological testing (ELISA) is preferable and diagnosis of acute infection is made at <12 weeks of gestation if it is +ve for IgG & IgM antibodies. 2. If IgM is -ve & IgG is +ve, repeat after 3 weeks and check for 4-fold rise. 3. If -ve in early pregnancy, perform test at 18-20 weeks of gestation. (Joul. Of OBGI Feb-2006). Summary TORCH screening is now accepted by clinicians as a reliable test for investigating pregnant women and infants for congenital, perinatal and neonatal TORCH infections. The IgG antibody in the pregnant woman may be a sign of past infection with one of these infectious agents. By testing a second blood sample drawn 2 weeks later, the level of antibody can be compared. If the second blood draw shows an increase in IgG antibody, it may indicate a recent infection with the infectious agent. IgM is never zero as it cross-reacts with many other IgMs and other proteins. IgM is a specific class of antibodies that seeks out virus particles. It is, therefore, the most useful indicator of the presence of a TORCH infection. Any general abnormal or positive presence gives high levels of IgM finding. IgM antibodies against TORCH organisms usually persist for about 3 months, while IgG antibodies remain detectable for a lifetime, providing immunity and preventing or reducing the severity of reinfection. Thus, 1. If IgM antibodies are present in a pregnant woman, a current or recent infection with the organism has occurred. 2. If IgM antibodies are absent and IgG antibodies are present and do not demonstrate an increase on serial testing several weeks later, it can be assumed that the person has had a previous infection by the corresponding organism, or has been vaccinated to prevent an infection. 3. If the serum of a person has no evidence of either IgM or IgG antibodies specific for the organism, then the person is at risk of infection because they do not have any demonstrable immunity. Reference: 1. Indian Journal of Medical Microbiology, (2002) 20 (1): 57-58, Prevalence of torch infections in Indian pregnant women, S Singh 2. Indian Journal of Medical Microbiology, (2003) 21 (2):108-110, seroprevalence of torch infection in bad obstetric history, D Turbadkar, M Mathur, M Rele. 3